Legal & General Group’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.04M Sell
84,755
-7,592
-8% -$519K ﹤0.01% 1409
2025
Q4
$5.47M Sell
92,347
-7,212
-7% -$391K ﹤0.01% 1513
2025
Q3
$5.49M Sell
99,559
-3,459
-3% -$180K ﹤0.01% 1524
2025
Q2
$4.44M Buy
103,018
+2,694
+3% +$104K ﹤0.01% 1605
2025
Q1
$3.97M Sell
100,324
-3,399
-3% -$150K ﹤0.01% 1632
2024
Q4
$4.23M Buy
103,723
+3,325
+3% +$138K ﹤0.01% 1659
2024
Q3
$3.92M Buy
100,398
+2,035
+2% +$81.1K ﹤0.01% 1686
2024
Q2
$4.3M Buy
98,363
+1,737
+2% +$83.9K ﹤0.01% 1597
2024
Q1
$4.61M Buy
96,626
+541
+0.6% +$24.3K ﹤0.01% 1559
2023
Q4
$4.54M Sell
96,085
-1,144
-1% -$47.5K ﹤0.01% 1565
2023
Q3
$4.63M Sell
97,229
-3,814
-4% -$208K ﹤0.01% 1489
2023
Q2
$5.88M Buy
101,043
+44,773
+80% +$2.69M ﹤0.01% 1367
2023
Q1
$4.02M Buy
56,270
+2,141
+4% +$170K ﹤0.01% 1529
2022
Q4
$3.81M Sell
54,129
-438
-0.8% -$30.9K ﹤0.01% 1557
2022
Q3
$3.31M Sell
54,567
-110,060
-67% -$7.38M ﹤0.01% 1597
2022
Q2
$10.4M Buy
164,627
+6,633
+4% +$432K ﹤0.01% 1061
2022
Q1
$10.1M Buy
157,994
+12,455
+9% +$833K ﹤0.01% 1152
2021
Q4
$10.4M Buy
145,539
+10,857
+8% +$826K ﹤0.01% 1181
2021
Q3
$9.61M Buy
134,682
+82,541
+158% +$6.51M ﹤0.01% 1203
2021
Q2
$4.24M Sell
52,141
-9,455
-15% -$760K ﹤0.01% 1618
2021
Q1
$4.65M Sell
61,596
-7,607
-11% -$554K ﹤0.01% 1593
2020
Q4
$5.24M Buy
69,203
+1,424
+2% +$92.7K ﹤0.01% 1435
2020
Q3
$3.35M Buy
67,779
+1,141
+2% +$64.4K ﹤0.01% 1535
2020
Q2
$3.5M Buy
66,638
+7,396
+12% +$351K ﹤0.01% 1471
2020
Q1
$2.32M Buy
59,242
+5,215
+10% +$305K ﹤0.01% 1518
2019
Q4
$4.72M Buy
54,027
+2,267
+4% +$198K ﹤0.01% 1395
2019
Q3
$4.39M Buy
51,760
+6,415
+14% +$572K ﹤0.01% 1360
2019
Q2
$4.77M Buy
45,345
+712
+2% +$71.5K ﹤0.01% 1297
2019
Q1
$4.71M Sell
44,633
-55,575
-55% -$5.58M ﹤0.01% 1209
2018
Q4
$8.34M Buy
100,208
+2,087
+2% +$189K 0.01% 883
2018
Q3
$9.99M Buy
98,121
+6,755
+7% +$652K 0.01% 869
2018
Q2
$7.4M Buy
91,366
+4,664
+5% +$371K 0.01% 958
2018
Q1
$6.34M Buy
86,702
+1,708
+2% +$128K ﹤0.01% 992
2017
Q4
$5.99M Buy
84,994
+2,205
+3% +$159K ﹤0.01% 992
2017
Q3
$5.17M Buy
82,789
+1,608
+2% +$95.2K ﹤0.01% 1010
2017
Q2
$4.65M Buy
81,181
+6,020
+8% +$354K ﹤0.01% 1024
2017
Q1
$4.58M Sell
75,161
-16,214
-18% -$917K ﹤0.01% 976
2016
Q4
$5.01M Sell
91,375
-103,724
-53% -$4.97M ﹤0.01% 888
2016
Q3
$9M Buy
195,099
+29,976
+18% +$1.27M 0.01% 682
2016
Q2
$5.62M Buy
+165,123
New +$5.16M 0.01% 743

Other funds holding NGVT

Legal & General Group's NGVT Position: Q1 2026 in Review

Legal & General Group reduced its Ingevity (NGVT) stake by 8.2% in Q1 2026, selling an estimated $519K and leaving 84,755 shares worth $6.04M. The position accounts for ﹤0.01% of the portfolio, ranked #1409.

Legal & General Group first reported a position in NGVT in Q2 2016 and has held it in 40 quarters since. The position peaked at $10.4M in Q4 2021. 307 funds tracked by Wall St. Rank hold NGVT as of Q1 2026.

  • Legal & General Group held 84,755 shares of Ingevity worth $6.04M as of Q1 2026.
  • Legal & General Group sold 7,592 Ingevity shares in Q1 2026, an estimated $519K.
  • Ingevity made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #1409 holding.
  • Legal & General Group first reported a position in Ingevity in Q2 2016 and has held it in 40 quarters since.
  • Legal & General Group's Ingevity position peaked at $10.4M in Q4 2021.
  • 307 funds tracked by Wall St. Rank held Ingevity as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.